The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A robust system for production of minicircle DNA vectors
Open accessAbstract
Minicircle DNA vectors allow sustained transgene expression in quiescent cells and tissues. To improve minicircle production, we genetically modified Escherichia coli to construct a producer strain that stably expresses a set of inducible minicircle-assembly enzymes, ΦC31 integrase and I-SceI homing endonuclease. This bacterial strain produces purified minicircles in a time frame and quantity similar to those of routine plasmid DNA preparation, making it feasible to use minicircles in place of plasmids in mammalian transgene expression studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some researchers use, therefore, minicircle DNA vectors devoid of prokaryotic and antibiotic DNA sequences for their AAV production [228].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [228]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Downregulating the Y-box binding protein 1 (YB1) in HEK293T cells did increase the physical titer by 47× for rAAV2, yet it failed to improve the yield for rAAV5 sequences for their AAV production [228].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [228]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
Datsenko, K., & Wanner, B. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.120163297 · Cited by 15,902
Cherepanov, P., & Wackernagel, W. (1995) · Gene · doi:10.1016/0378-1119(95)00193-a · Cited by 1,952
An efficient recombination system for chromosome engineering in Escherichia coli
Yu, D., Ellis, H. M., Lee, E.-C., Jenkins, N. A., Copeland, N. G., & Court, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127597 · Cited by 1,688
A nonviral minicircle vector for deriving human iPS cells
Jia, F., Wilson, K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., Panetta, N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A., et al. (2010) · Nature Methods · doi:10.1038/nmeth.1426 · Cited by 734
Self-citationChen, Z.-Y., He, C.-Y., Ehrhardt, A., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00168-0 · Cited by 463
Self-citationThorpe, H. M., & Smith, M. C. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5505 · Cited by 434
Khlebnikov, A., Keasling, J. D., Wanner, B. L., Skaug, T., & Datsenko, K. A. (2001) · Microbiology · doi:10.1099/00221287-147-12-3241 · Cited by 289
A new DNA vehicle for nonviral gene delivery: supercoiled minicircle
Darquet, A.-M., Cameron, B., Wils, P., Scherman, D., & Crouzet, J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300540 · Cited by 250
Tan, Y., Li, S., Pitt, B. R., & Huang, L. (1999) · Human Gene Therapy · doi:10.1089/10430349950017149 · Cited by 236
Chen, Z.-Y., He, C.-Y., & Kay, M. A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.126 · Cited by 180
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 326
Precise kilobase-scale genomic insertions in mammalian cells using PASTE
Fell, C. W., Schmitt-Ulms, C., Tagliaferri, D. V., Gootenberg, J. S., & Abudayyeh, O. O. (2024) · Nature Protocols · doi:10.1038/s41596-024-01090-z · Cited by 8
Hua, W., Hsu, J. C., Chen, Y., Chang, P. S., Wen, K. K., Wang, P., Yang, W., Shen, C., Yu, Y., Chen, Y., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202201654r · Cited by 8
Yu, J., Zhang, H., Han, P., Jiang, X., Li, J., Li, B., Yang, S., He, C., Mao, S., Dang, Y., et al. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.019 · Cited by 8
Self-citationEvaluation of DNA Vaccine Candidates against Foot-and-Mouth Disease Virus in Cattle
Puckette, M. C., Clark, B. A., BARRERA, J. D. C., Neilan, J. G., & Rasmussen, M. V. (2023) · Vaccines · doi:10.3390/vaccines11020386 · Cited by 8
Reprogramming for cardiac regeneration
Raynaud, C. M., Ahmad, F. S., Allouba, M., Abou-Saleh, H., Lui, K. O., & Yacoub, M. H. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.44 · Cited by 8
Delaney, A. M., Adams, C. F., Fernandes, A. R., al-Shakli, A. F., Sen, J., Carwardine, D. R., Granger, N. P., & Chari, D. M. (2017) · Nanoscale · doi:10.1039/c7nr00811b · Cited by 8
Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy
Robinson, E. R., Gowrishankar, G., D’Souza, A. L., Kheirolomoom, A., Haywood, T., Hori, S. S., Chuang, H., Zeng, Y., Tumbale, S. K., Aalipour, A., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.026 · Cited by 8
Saleh, N. A., Gagea, M. A., Vitija, X., Kilangodi, S., Zarea, A. A., Janovic, T., Schmidt, J. C., Deng, C. X., & Kanada, M. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100102 · Cited by 7
Efficient and rapid fluorescent protein knock-in with universal donors in mouse embryonic stem cells
Shi, Y., Kopparapu, N., Ohler, L. S., & Dickinson, D. J. (2023) · Development · doi:10.1242/dev.201367 · Cited by 7
Yang, P., Yang, J., Ting, L., Liu, Q., Yin, Y., Chen, D., & Yang, S. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00339 · Cited by 7
Funato, K., Miyake, N., Sekiba, K., Miyakawa, Y., Seimiya, T., Shibata, C., Kishikawa, T., & Otsuka, M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000313 · Cited by 7
Eom, Y. J., Kim, J.-W., Rim, Y. A., Lim, J., Jung, S. I., & Ju, J. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-51957-0 · Cited by 7
CRISPR/Cas9-mediated genome editing: from basic research to gene therapy
Goel, R. (2024) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20241589 · Cited by 7
Chang, T.-Y., Chung, C.-Y., Chuang, W.-M., Li, L., Jeng, L., & Ma, W. (2014) · BioMed Research International · doi:10.1155/2014/156356 · Cited by 7
Augmenter of liver regeneration (ALR) restrains concanavalin A-induced hepatitis in mice
Mu, M., Zhang, Z., Cheng, Y., Liu, G., Chen, X., Wu, X. T., Zhuang, C., Liu, B., Kong, X., & You, S. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.03.040 · Cited by 7
Wang, T., Chen, Y., & Ronald, J. A. (2019) · Gene Therapy · doi:10.1038/s41434-019-0067-6 · Cited by 7
Cai, J., Jiang, S., Liao, J., Huiping, F., Chen, P., Shi, S., Huang, S., Chen, G., Xu, J., & Wang, Z. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142242 · Cited by 7
Chung, K., & Booth, M. J. (2023) · Chemical Science · doi:10.1039/d3sc02761a · Cited by 7
Kacherovsky, N. A., Harkey, M. A., Blau, C. A., Giachelli, C. M., & Pun, S. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks213 · Cited by 7
Enhanced gene disruption by programmable nucleases delivered by a minicircle vector
Dad, A.-B., Ramakrishna, S., Song, M., & Kim, S. (2014) · Gene Therapy · doi:10.1038/gt.2014.76 · Cited by 7
Anderson, B. G., & Stivers, J. T. (2014) · Biochemistry · doi:10.1021/bi500571q · Cited by 7
Makhija, H., Roy, S., Hoon, S. S., Ghadessy, F. J., Wong, D., Jaiswal, R., Campana, D., & Dröge, P. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky500 · Cited by 8
Anticodon-edited transfer RNAs (ACE-tRNAs) encoded as therapeutic nonviral minimal DNA vectors
Porter, J. J., Ko, W., Sorensen, E. G., Cheung, Z., Thrasher, K., Couch, T. A., Gabell, J., Shwe, V., Hyatt, J., Licata, J. B., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag082 · Cited by 6
An advanced method for the small-scale production of high-quality minicircle DNA
Mitdank, H., Sama, S., Tröger, M., Testa, M. F., Ferrarese, M., Balestra, D., Pinotti, M., & Weng, A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120830 · Cited by 6
Pang, X., Chen, G., Huang, P., Zhang, P., Liu, J., Hou, X., He, C., Chen, P., Xie, Y.-W., Zhao, J., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.02.014 · Cited by 6
Self-citationOu, H., & Lei, T. (2013) · IUBMB Life · doi:10.1002/iub.1119 · Cited by 6
Guo, X., Chen, D., Cai, Q., Huang, Z., Xu, W., Peng, L., & Chen, P. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00250-9 · Cited by 6
Evaluation of BMP-2 Minicircle DNA for Enhanced Bone Engineering and Regeneration
Zimmermann, A., Hercher, D., Regner, B., Frischer, A., Sperger, S., Redl, H. R., & Hacobian, A. (2020) · Current Gene Therapy · doi:10.2174/1566523220666200427121350 · Cited by 6
Suicide nanoplasmids coding for ribosome-inactivating proteins
Mitdank, H., Tröger, M., Sonntag, A., Shirazi, N. A., Woith, E., Fuchs, H., Kobelt, D., Walther, W., & Weng, A. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106107 · Cited by 6
Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia
Ma, S., Gao, X.-X., Zhou, G., Zhang, H., Yang, J.-M., Wang, W., Song, X., Chen, H., & Lu, D. (2022) · Gene · doi:10.1016/j.gene.2022.146289 · Cited by 6
Stenler, S., Lundin, K. E., Hansen, L. F., Petkov, S., Mozafari, N., Isaguliants, M. G., Blomberg, P., Smith, C. I. E., Goldenberg, D. M., Chang, C., et al. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1338546 · Cited by 6
Chen, P., Liu, Y., Zhao, J., Pang, X., Zhang, P., Hou, X., Chen, P., He, C., Wang, Z., & Chen, Z.-Y. (2018) · Biomaterials Science · doi:10.1039/c7bm01143a · Cited by 6
Self-citationKrajewski, W. A. (2019) · BioEssays · doi:10.1002/bies.201900136 · Cited by 6
Ata-abadi, N. S., Dormiani, K., Khazaie, Y., Ghaedi, K., Forouzanfar, M., Lachinani, L., Rezaei, N., Kiani‐Esfahani, A., & Nasr‐Esfahani, M. H. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3864-z · Cited by 6
Supercoiled DNA recognition and cleavage control in topoisomerase VI
Richman, D. E., Wendorff, T. J., Rashid, F., Beck, C., Yan, Q., Johnson, H. R., Eckerty, R. A., Fogg, J. M., Baker, M. L., Zechiedrich, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69491-0 · Cited by 5
Viral vectors for gene delivery to the central nervous system
Ingusci, S., Hall, B. L., Goins, W. F., Cohen, J. B., & Glorioso, J. C. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00001-0 · Cited by 7
Oliynyk, R. T., Mahas, A., Karpinski, E., & Church, G. M. (2025) · Communications Biology · doi:10.1038/s42003-025-09157-7 · Cited by 5
Cancer Detection Using an Artificial Secretable MicroRNA Found in Blood and Urine
Shueng, P., Shih, K., Gambhir, S. S., Kuo, D., & Chuang, H. (2022) · Biomedicines · doi:10.3390/biomedicines10030621 · Cited by 5
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine
Dhanjal, D. S., Singh, R., Sharma, V., Nepovimová, E., Adam, V., Kuča, K., & Chopra, C. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230503144619 · Cited by 5
Wu, D. J., Dixit, N., Suzuki, É., Nguyen, T. H., Shin, H. S., Davis, J., Maverakis, E. M., & Adamopoulos, I. E. (2014) · Journal of Visualized Experiments · doi:10.3791/51810 · Cited by 5
Gaspar, V. M., Cruz, C., Queiroz, J. A., Pichon, C., Correia, I. J., & de Sousa, F. P. (2016) · Separation and Purification Technology · doi:10.1016/j.seppur.2016.10.054 · Cited by 5
Production of Minicircle DNA Vectors Using Site-Specific Recombinases
Ata-abadi, N. S., Rezaei, N., Dormiani, K., & Nasr‐Esfahani, M. H. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7169-5_20 · Cited by 5
Preparation of minicircle DNA vectors for gene knock-in to mammalian cells
Kawabe, Y., Hamaoka, M., Kuno, A., Yoshimura, Y., & Kamihira, M. (2025) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2025.05.005 · Cited by 4
Minicircle DNA vectors: A breakthrough in non-viral delivery of CRISPR base editors?
Kanada, M., & Gilad, A. A. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102275 · Cited by 4
A new version of targeted minicircle producer system for EBV-positive human nasopharyngeal carcinoma
Zuo, Y., Liao, S., Xu, Z., Xie, J., Huang, W., & Yu, Z. (2014) · Oncology Reports · doi:10.3892/or.2014.3486 · Cited by 4
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
van Essen, M. J., Riepsaame, J., & Jacob, J. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0063 · Cited by 4
A robust knock-in approach using a minimal promoter and a minicircle
Keating, M. K., Hagle, R., Osorio-Méndez, D., Rodriguez, A., Almutawa, S. F. A. M. A., & Kang, J. (2023) · Developmental Biology · doi:10.1016/j.ydbio.2023.10.002 · Cited by 4
Tombak, E.-M., Männik, A., Burk, R. D., Grand, R. L., Ustav, E., & Ustav, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211235 · Cited by 4
Kim, J.-W., Park, N., Kang, J., Kim, Y., Jung, H., Rim, Y. A., & Ju, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169069 · Cited by 4
Rehm, T. M., Parpoulas, C., Straub, E., Iftner, T., & Stubenrauch, F. (2025) · Tumour Virus Research · doi:10.1016/j.tvr.2025.200328 · Cited by 3
Host cell in vivo production of the synthetic drug anti–CD25/IL‐10 using minicircle vector
Lim, S. W., Shin, Y., Luo, K., Quan, Y., Ko, E. J., Chung, B. H., & Yang, C. W. (2019) · The FASEB Journal · doi:10.1096/fj.201900833r · Cited by 3
Than, P. A., Davis, C. R., Rennert, R. C., Morrison, S. D., Findlay, M. W., Kay, M. A., & Gurtner, G. C. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000008630 · Cited by 3
Self-citationLim, S. W., Shin, Y., Cui, S., Ko, E. J., Yoo, S., Chung, B. H., & Yang, C. W. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.299 · Cited by 3
Large T antigen mediated target gene replication improves site-specific recombination efficiency
Wang, Z., Chen, C., & Ge, X. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1377167 · Cited by 3
Replicating Minicircles: Overcoming the Limitations of Transient and Stable Expression Systems
Nehlsen, K., Broll, S., Kandimalla, R., Heinz, N., Heine, M. A., Binius, S., Schambach, A., & Bode, J. (2013) · Wiley eBooks · doi:10.1002/9783527670420.ch8 · Cited by 3
High-Potency Polypeptide-based Inhibition of Enveloped-virus GlycoproteinsPreprint
Ma, J., Acevedo, A. C., & Wang, Q. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.05.438537 · Cited by 3
Mao, T., Du, X., Li, Y., Zhou, Z., Li, D., Zheng, L., Zhang, T., Li, G., Yang, D., Chen, X., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70390 · Cited by 2
Sekiba, K., Miyake, N., Miyakawa, Y., Shibata, C., Seimiya, T., Kishikawa, T., Fujishiro, M., & Otsuka, M. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000757 · Cited by 2
Qiu, B., Lorino, M., Li, Y., He, Z., Wang, X., Wang, W., & Lara‐Sáez, I. (2026) · The Journal of Gene Medicine · doi:10.1002/jgm.70087 · Cited by 2
Ibragimov, R., Babok, S., Lototskaja, E., Ivanova, L. B., Mikhailava, N., Zaikina, L., Piirsoo, M., & Piirsoo, A. (2025) · Journal of Virology · doi:10.1128/jvi.00918-25 · Cited by 2
Protocol for minicircle production for gene therapy without subsequent cleanup steps
Do, J., Verma, G., Maurice, Y., Abdumanobova, M., Deng, Z., Kalin, T. V., & Kalinichenko, V. V. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.103982 · Cited by 2
Yuen, V. F. K., Yuan, D., Zhou, Y., Wang, H., Tan, D. Z. J., & Zhou, K. (2023) · Biochemical Engineering Journal · doi:10.1016/j.bej.2023.109007 · Cited by 2
Advancements in Non Viral Gene Therapy for Hemophilia
Fletcher, B. S. (2012) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.s1-002 · Cited by 2
Alves, C. P. A., Prazeres, D. M. F., & Monteiro, G. A. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114285 · Cited by 2
Evans, M. M., Liu, S., Krautner, J. S., Seguin, C., Leung, R., & Ronald, J. A. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102248 · Cited by 2
Zechiedrich, L., & Fogg, J. M. (2019) · Technology & Innovation · doi:10.21300/20.4.2019.427 · Cited by 2
Development of viral & non-viral episomal vectors for gene therapy applications
Kymäläinen, H. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
High-Potency Polypeptide-based Interference for Coronavirus Spike GlycoproteinsPreprint
Wang, Q., Ma, J., & Acevedo, A. C. (2021) · Research Square · doi:10.21203/rs.3.rs-388285/v1 · Cited by 2
Chen, Y., Hua, W., Hsu, J. C., Chang, P. S., Wen, K. K., Huang, Y.-W., Tsai, J.-C., Kao, Y.-H., Wu, P.-H., Wang, P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.03.490469 · Cited by 2
Wu, H., Zhao, W., Chen, X., Wang, Y., Wei, S., Xiang, B., Shi, Y., Li, Z., Yao, Y., Xie, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202508870 · Cited by 1
Self-citationLópez-Seijas, J., Iglesias-Fente, A., Ramil-Bouzas, A., Paniagua-Barro, S., Fafián-Labora, J. A., & Rey‐Rico, A. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04867-5 · Cited by 1
Viral and Plasmid Transduction Systems: Methods to Modify Immune Cells for Cancer Immunotherapy
Xu, J. (2011) · Cited by 1
Gene Nanovector for Genome Therapy
Ma, D., & Xi, Z. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_60 · Cited by 1
The POU-HD TFs impede the replication efficiency of several human papillomavirus genomes
Kala, M., Babok, S., Mikhailava, N., Piirsoo, M., & Piirsoo, A. (2024) · Virology Journal · doi:10.1186/s12985-024-02334-w · Cited by 1
Bazazzadegan, N., Hasanzad, M., & Abedini, S. S. (2024) · Springer eBooks · doi:10.1007/978-981-97-4974-4_9 · Cited by 1
Nonviral Delivery Systems for Gene Therapy for Retina and Posterior Segment Disease
del Pozo‐Rodríguez, A., Torrecilla, J., Rodríguez‐Gascón, A., & Solinís, M. Á. (2018) · Springer eBooks · doi:10.1007/978-3-319-95807-1_8 · Cited by 1
Liposome-Templated Hydrogel Nanoparticles for Targeted Delivery of CRISPR/Cas9 to Brain Tumors
Chen, Z., Chen, A. T., & Zhou, J. (2020) · Neuromethods · doi:10.1007/978-1-0716-1052-7_10 · Cited by 1
Self-citationMayrhofer, P., Jug, H., Štrancar, A., Paolo, A. D., Jost, L., Zimmermann, A., & Redl, H. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/300236 · Cited by 1
Webber, B. R., Johnson, M. J., Slipek, N. J., Lahr, W. S., DeFeo, A. P., Skeate, J. G., Qiu, X., Rathmann, B., Diers, M. D., Wick, B. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.12.468427 · Cited by 1
Shi, S. J., Lin, Y., Ye, J. Z., Kwok, A., Want, K. Z., Cai, J. Z., Hu, M. M., Liu, A. Y., Li, K. J., Guo, B. Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.02.679775 · Cited by 1
Nonviral Gene Therapy—The Challenge of Mobilizing DNA
Mikkelsen, J. G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2389-2_4
Gene Therapy Challenges in Arthritis
Denys, A., Thiolat, A., Boissier, M., & Natach, B. (2011) · InTech eBooks · doi:10.5772/19300
Characterization and applications in muscle of a Minicircle vector for Nonviral gene therapy
Stenler, S. (2015) · Figshare
Development of new tools for the production of plasmid DNA biopharmaceuticals
Bower, D. M. (2012) · DSpace@MIT (Massachusetts Institute of Technology)
Synthetic immunosurveillance systems: Nanodevices to monitor physiological events
Woappi, Y., Jangiti, R., & Singh, O. V. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.04.056
Gene delivery to neural stem cells using minicircles and plasmids without CpG motifs
Reis, M. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Strategies to improve gene expression and targeting for DNA vaccine development
Skinner, N. (2013) · University of Minnesota Digital Conservancy (University of Minnesota)
Clinical Applications of Induced Pluripotent Stem Cells in Cancer
Fernandez, T. D. S., Mencalha, A. L., & Fernandez, C. D. S. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-33270-3_7
Sum, C. H. (2014) · UWSpace (University of Waterloo)
Gene Therapy for Cystic Fibrosis: Hurdles to Overcome for Successful Clinical Translation
Sainz-Ramos, M., Qtaish, N. A., Gallego, I., Villate-Beitia, I., López-Méndez, T. B., Puras, G., & Pedraz, J. L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79719
Zaini, M. N. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.41223
Jiang, Y., Yang, G., & Wang, C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0872-2_1
Genetic modification of adipose-derived stem cells for bone regeneration
Shah, H. N., Shen, A. H., Adem, S., Salhotra, A., Longaker, M. T., & Wan, D. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819376-1.00010-x
Kim, J.-W., Park, N., Kang, J., Kim, Y., Jung, H., & Ju, J. H. (2020) · Research Square · doi:10.21203/rs.3.rs-88110/v1
Enhanced Efficacy of Plasmid DNA Vaccines for Cancer Therapy
Dietz, W. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
De prólogos, reuniones y diabetes
Saavedra, F. J. M. (2013) · Cadernos de atención primaria
Metadata
- Authors
- Kay, M. A., He, C.-Y., & Chen, Z.-Y.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Kay, Mark A
- ORCID
- Kay, Mark A
- Venue
- Nature Biotechnology
- Published
- 2010-11-21
- Volume
- 28
- Issue
- 12
- Pages
- 1287-1289
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4144359
- OpenAlex
- W2079903460
- Cited by
- 329
- References
- 18
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 21 · 2023: 20 · 2022: 17 · 2021: 28 · 2020: 20 · 2019: 22 · 2018: 19 · 2017: 17 · 2016: 28 · 2015: 24 · 2014: 31 · 2013: 23 · 2012: 16
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL064274, R01HL064274)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- transgene expression, gene transfer
- MeSH terms
- Biotechnology, Cloning, Molecular, DNA, Circular, Escherichia coli, Genetic Vectors, Plasmids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review